About Albumin
FDA: "SAFE" Study Resolves Prior Albumin Safety Concerns Raised by Flawed 1998 Cochrane Meta-Analysis
New Data Reinforces Advantage of Albumin Over Saline in Animal Stroke Treatment
New Study Shows Albumin Strongly Improves Outcomes Versus Saline in Patients with Subarachnoid Hemorrhage
FDA Approves Amended 6% Hetastarch Labeling New Warning Against Use in Cardiac Surgery
June 2003 Study Volume Expansion with Albumin Decreases Mortality After Coronary Artery Bypass Graft Surgery
Home
|
About Us
|
News
|
Terms Of Use
|
Privacy
|
Site Map
©2008 FFF Enterprises, Inc.
